Co-Authors
This is a "connection" page, showing publications co-authored by Mario Karolyi and Thomas Stimpfl.
Connection Strength
0.294
-
High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Front Pharmacol. 2021; 12:704767.
Score: 0.238
-
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19). Ann Intern Med. 2020 10 20; 173(8):670-672.
Score: 0.055